JP2017537941A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017537941A5 JP2017537941A5 JP2017531577A JP2017531577A JP2017537941A5 JP 2017537941 A5 JP2017537941 A5 JP 2017537941A5 JP 2017531577 A JP2017531577 A JP 2017531577A JP 2017531577 A JP2017531577 A JP 2017531577A JP 2017537941 A5 JP2017537941 A5 JP 2017537941A5
- Authority
- JP
- Japan
- Prior art keywords
- fucnac
- mannac
- galnac
- pyr
- gal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001720 carbohydrates Chemical class 0.000 claims 11
- 241000894006 Bacteria Species 0.000 claims 4
- 241001465754 Metazoa Species 0.000 claims 2
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 150000004676 glycans Chemical class 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 229920001282 polysaccharide Polymers 0.000 claims 2
- 239000005017 polysaccharide Substances 0.000 claims 2
- 230000001681 protective effect Effects 0.000 claims 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 2
- 208000031729 Bacteremia Diseases 0.000 claims 1
- 206010006458 Bronchitis chronic Diseases 0.000 claims 1
- 206010009137 Chronic sinusitis Diseases 0.000 claims 1
- 206010010741 Conjunctivitis Diseases 0.000 claims 1
- 201000009906 Meningitis Diseases 0.000 claims 1
- 206010033078 Otitis media Diseases 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 206010006451 bronchitis Diseases 0.000 claims 1
- 208000007451 chronic bronchitis Diseases 0.000 claims 1
- 208000027157 chronic rhinosinusitis Diseases 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 238000010324 immunological assay Methods 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 0 C[C@](C(*)C1OC)OC(CO)C1O Chemical compound C[C@](C(*)C1OC)OC(CO)C1O 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14197832 | 2014-12-12 | ||
| EP14197832.0 | 2014-12-12 | ||
| EP15163253 | 2015-04-10 | ||
| EP15163253.6 | 2015-04-10 | ||
| PCT/EP2015/060756 WO2016091399A1 (en) | 2014-12-12 | 2015-05-15 | Vaccines against streptococcus pneumoniae serotype 4 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017537941A JP2017537941A (ja) | 2017-12-21 |
| JP2017537941A5 true JP2017537941A5 (https=) | 2018-06-21 |
| JP6622804B2 JP6622804B2 (ja) | 2019-12-18 |
Family
ID=53267330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017531577A Active JP6622804B2 (ja) | 2014-12-12 | 2015-05-15 | ストレプトコッカス ニューモニアエ（Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｎｅｕｍｏｎｉａｅ）血清型４に対するワクチン |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US10188718B2 (https=) |
| EP (1) | EP3230297B1 (https=) |
| JP (1) | JP6622804B2 (https=) |
| WO (1) | WO2016091399A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3331556B8 (en) * | 2015-12-17 | 2019-02-27 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Synthetic vaccines against streptococcus pneumoniae serotype 2 |
| GB201711635D0 (en) | 2017-07-19 | 2017-08-30 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| US20220054632A1 (en) | 2018-12-12 | 2022-02-24 | Glaxosmithkline Biologicals Sa | Modified carrier proteins for o-linked glycosylation |
| JP2025537898A (ja) | 2022-11-22 | 2025-11-20 | ファイザー・インク | コンジュゲートさせた莢膜糖類抗原を含む免疫原性組成物およびその使用 |
| WO2025057078A1 (en) | 2023-09-14 | 2025-03-20 | Pfizer Inc. | Adjuvanted immunogenic compositions comprising conjugated pneumococcal capsular saccharide antigens and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1224300A1 (zh) * | 2013-07-07 | 2017-08-18 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | 合成针对1型肺炎链球菌的疫苗 |
| EP2851092A1 (en) * | 2013-09-18 | 2015-03-25 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3 |
| CN106879257B (zh) * | 2014-09-26 | 2020-08-11 | 马普科技促进协会 | 针对肺炎链球菌(Streptococcus pneumoniae)血清型8的疫苗 |
| EP3331556B8 (en) * | 2015-12-17 | 2019-02-27 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Synthetic vaccines against streptococcus pneumoniae serotype 2 |
-
2015
- 2015-05-15 EP EP15724583.8A patent/EP3230297B1/en active Active
- 2015-05-15 WO PCT/EP2015/060756 patent/WO2016091399A1/en not_active Ceased
- 2015-05-15 JP JP2017531577A patent/JP6622804B2/ja active Active
- 2015-05-15 US US15/534,676 patent/US10188718B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017532321A5 (https=) | ||
| JP2017537941A5 (https=) | ||
| Dunne et al. | Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination | |
| Ogunniyi et al. | c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection | |
| JP2020533438A5 (https=) | ||
| Parameswarappa et al. | A semi-synthetic oligosaccharide conjugate vaccine candidate confers protection against Streptococcus pneumoniae serotype 3 infection | |
| JP2020533437A5 (https=) | ||
| JP2020533442A5 (https=) | ||
| HRP20240847T1 (hr) | Novi polisaharid i njegove upotrebe | |
| JP2021535921A (ja) | 多価肺炎球菌ワクチン | |
| Adamu et al. | Membrane proteins of Mycoplasma bovis and their role in pathogenesis | |
| JP2013079285A5 (https=) | ||
| IL274500B2 (en) | Glycoconjugation process | |
| JP2016040284A5 (https=) | ||
| CN101883583A (zh) | 含有肺炎链球菌荚膜多糖缀合物的疫苗 | |
| CN111065417B (zh) | 免疫原性组合物 | |
| JP2016526564A5 (https=) | ||
| JP2015521202A5 (https=) | ||
| JP2021528059A5 (https=) | ||
| Mirzaei et al. | Synthesis of conjugated PIA–rSesC and immunological evaluation against biofilm-forming Staphylococcus epidermidis | |
| WO2016198170A8 (en) | Vaccines against streptococcus pneumoniae serotype 5 | |
| Kurashova et al. | Various adjuvants effect on immunogenicity of Puumala virus vaccine | |
| JP2011504535A5 (https=) | ||
| Ala'Aldeen et al. | Immunogenicity and cross-reactivity of the 70-Kda iron-regulated protein of Neisseria meningitidis in man and animals | |
| Hu et al. | Roles of virulence genes (PsaA and CpsA) on the invasion of Streptococcus pneumoniae into blood system |